Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase EARLY_PHASE1 1

Status

Completed 18Unknown 9Recruiting 7Terminated 5Active not recruiting 5Not yet recruiting 4Withdrawn 2Suspended 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 3CRC 1

Interventions

Drug Therapy 108Cisplatin 96Radiotherapy 87Carboplatin 84Bevacizumab 81Oxaliplatin 72tislelizumab 69Capecitabine 67Cyclophosphamide 65Gemcitabine 63toripalimab 60Paclitaxel 59sintilimab 55Specimen Handling 55pembrolizumab 54Surgical Procedures, Operative 51Magnetic Resonance Spectroscopy 49Fluorouracil 48anlotinib 47Immune Checkpoint Inhibitors 45Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 37camrelizumab 36lenvatinib 34fludarabine 34Radiosurgery 33Leucovorin 32venetoclax 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × IFL protocol × Clear all
NCT07359456 2026-05-19

COLIBRI-GI

UNICANCER

Phase 2 Not yet recruiting
130 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07381309 2026-04-28

VVSHIP

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Not yet recruiting
114 enrolled
Gastrointestinal

CRC

NCT07318389 2026-02-27

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Not yet recruiting
100 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07021950 2025-06-15

AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer

Sun Yat-sen University

Phase 2 Not yet recruiting
130 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡